QSAM Biosciences, Inc.

OTC:QSAM

6.1 (USD) • At close November 27, 2023
Bedrijfsnaam QSAM Biosciences, Inc.
Symbool QSAM
Munteenheid USD
Prijs 7
Beurswaarde 23,015,580
Dividendpercentage 0%
52-weken bereik 3.51 - 7.5
Industrie Biotechnology
Sector Healthcare
CEO Mr. Douglas R. Baum
Website https://qsambio.com

An error occurred while fetching data.

Over QSAM Biosciences, Inc.

QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc.

Vergelijkbare Aandelen

Medicure Inc. logo

Medicure Inc.

MCUJF

1.23 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)